Update on the Gleason grading system for prostate cancer

Results of an International Consensus Conference of Urologic Pathologists

Jonathan I. Epstein, William C. Allsbrook, Mahul Amin, Lars L. Egevad

Research output: Contribution to journalArticle

77 Citations (Scopus)

Abstract

The Gleason system for prostate cancer was based on a study of 270 patients from the Minneapolis Veterans Administration Hospital in 1966-1967. In 1974, Gleason and the Veterans Administrative Cooperative Urological Research Group expanded this study to 1032 men. These studies formed the basis of the Gleason grading system, which is now endorsed as the primary grading system for prostate cancer by the World Health Organization, the Armed Forces Institute of Pathology Fascicle on prostate cancer, the Association of Directors of Anatomic and Surgical Pathology, and the College of American Pathologists. In the nearly 40 years since its inception, several aspects about prostate cancer and its management have changed, most notably serum prostate-specific antigen, transrectal ultrasonography, 18-gauge needle biopsy sampling, immunohistochemistry for the diagnosis of cancer, and radical prostatectomy and radiation therapy as primary treatment modalities. Several aspects of the disease, and consequently the reporting needs, have changed such as reporting cancer on multiple cases in needle biopsies, multiple nodules in prostatectomy, tertiary patterns, variants and variations in prostate cancer. The application of the Gleason system, therefore, has varied considerably in contemporary surgical pathology practice. An International Consensus Conference attended by 80 urologic pathologists from 20 countries was convened to discuss clarifications and modifications to the Gleason system. This article serves as a brief overview and summary of the proceedings that have been published in detail in recent literature.

Original languageEnglish (US)
Pages (from-to)57-59
Number of pages3
JournalAdvances in anatomic pathology
Volume13
Issue number1
DOIs
StatePublished - Jan 1 2006

Fingerprint

Neoplasm Grading
Prostatic Neoplasms
Surgical Pathology
Needle Biopsy
Prostatectomy
Veterans Hospitals
United States Department of Veterans Affairs
Veterans
Prostate-Specific Antigen
Ultrasonography
Neoplasms
Radiotherapy
Immunohistochemistry
Pathologists
Pathology
Serum
Research

All Science Journal Classification (ASJC) codes

  • Anatomy
  • Pathology and Forensic Medicine

Cite this

Update on the Gleason grading system for prostate cancer : Results of an International Consensus Conference of Urologic Pathologists. / Epstein, Jonathan I.; Allsbrook, William C.; Amin, Mahul; Egevad, Lars L.

In: Advances in anatomic pathology, Vol. 13, No. 1, 01.01.2006, p. 57-59.

Research output: Contribution to journalArticle

@article{f20469244eb54cc4a95a0f70ffd5658c,
title = "Update on the Gleason grading system for prostate cancer: Results of an International Consensus Conference of Urologic Pathologists",
abstract = "The Gleason system for prostate cancer was based on a study of 270 patients from the Minneapolis Veterans Administration Hospital in 1966-1967. In 1974, Gleason and the Veterans Administrative Cooperative Urological Research Group expanded this study to 1032 men. These studies formed the basis of the Gleason grading system, which is now endorsed as the primary grading system for prostate cancer by the World Health Organization, the Armed Forces Institute of Pathology Fascicle on prostate cancer, the Association of Directors of Anatomic and Surgical Pathology, and the College of American Pathologists. In the nearly 40 years since its inception, several aspects about prostate cancer and its management have changed, most notably serum prostate-specific antigen, transrectal ultrasonography, 18-gauge needle biopsy sampling, immunohistochemistry for the diagnosis of cancer, and radical prostatectomy and radiation therapy as primary treatment modalities. Several aspects of the disease, and consequently the reporting needs, have changed such as reporting cancer on multiple cases in needle biopsies, multiple nodules in prostatectomy, tertiary patterns, variants and variations in prostate cancer. The application of the Gleason system, therefore, has varied considerably in contemporary surgical pathology practice. An International Consensus Conference attended by 80 urologic pathologists from 20 countries was convened to discuss clarifications and modifications to the Gleason system. This article serves as a brief overview and summary of the proceedings that have been published in detail in recent literature.",
author = "Epstein, {Jonathan I.} and Allsbrook, {William C.} and Mahul Amin and Egevad, {Lars L.}",
year = "2006",
month = "1",
day = "1",
doi = "10.1097/01.pap.0000202017.78917.18",
language = "English (US)",
volume = "13",
pages = "57--59",
journal = "Advances in Anatomic Pathology",
issn = "1072-4109",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Update on the Gleason grading system for prostate cancer

T2 - Results of an International Consensus Conference of Urologic Pathologists

AU - Epstein, Jonathan I.

AU - Allsbrook, William C.

AU - Amin, Mahul

AU - Egevad, Lars L.

PY - 2006/1/1

Y1 - 2006/1/1

N2 - The Gleason system for prostate cancer was based on a study of 270 patients from the Minneapolis Veterans Administration Hospital in 1966-1967. In 1974, Gleason and the Veterans Administrative Cooperative Urological Research Group expanded this study to 1032 men. These studies formed the basis of the Gleason grading system, which is now endorsed as the primary grading system for prostate cancer by the World Health Organization, the Armed Forces Institute of Pathology Fascicle on prostate cancer, the Association of Directors of Anatomic and Surgical Pathology, and the College of American Pathologists. In the nearly 40 years since its inception, several aspects about prostate cancer and its management have changed, most notably serum prostate-specific antigen, transrectal ultrasonography, 18-gauge needle biopsy sampling, immunohistochemistry for the diagnosis of cancer, and radical prostatectomy and radiation therapy as primary treatment modalities. Several aspects of the disease, and consequently the reporting needs, have changed such as reporting cancer on multiple cases in needle biopsies, multiple nodules in prostatectomy, tertiary patterns, variants and variations in prostate cancer. The application of the Gleason system, therefore, has varied considerably in contemporary surgical pathology practice. An International Consensus Conference attended by 80 urologic pathologists from 20 countries was convened to discuss clarifications and modifications to the Gleason system. This article serves as a brief overview and summary of the proceedings that have been published in detail in recent literature.

AB - The Gleason system for prostate cancer was based on a study of 270 patients from the Minneapolis Veterans Administration Hospital in 1966-1967. In 1974, Gleason and the Veterans Administrative Cooperative Urological Research Group expanded this study to 1032 men. These studies formed the basis of the Gleason grading system, which is now endorsed as the primary grading system for prostate cancer by the World Health Organization, the Armed Forces Institute of Pathology Fascicle on prostate cancer, the Association of Directors of Anatomic and Surgical Pathology, and the College of American Pathologists. In the nearly 40 years since its inception, several aspects about prostate cancer and its management have changed, most notably serum prostate-specific antigen, transrectal ultrasonography, 18-gauge needle biopsy sampling, immunohistochemistry for the diagnosis of cancer, and radical prostatectomy and radiation therapy as primary treatment modalities. Several aspects of the disease, and consequently the reporting needs, have changed such as reporting cancer on multiple cases in needle biopsies, multiple nodules in prostatectomy, tertiary patterns, variants and variations in prostate cancer. The application of the Gleason system, therefore, has varied considerably in contemporary surgical pathology practice. An International Consensus Conference attended by 80 urologic pathologists from 20 countries was convened to discuss clarifications and modifications to the Gleason system. This article serves as a brief overview and summary of the proceedings that have been published in detail in recent literature.

UR - http://www.scopus.com/inward/record.url?scp=33644943429&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644943429&partnerID=8YFLogxK

U2 - 10.1097/01.pap.0000202017.78917.18

DO - 10.1097/01.pap.0000202017.78917.18

M3 - Article

VL - 13

SP - 57

EP - 59

JO - Advances in Anatomic Pathology

JF - Advances in Anatomic Pathology

SN - 1072-4109

IS - 1

ER -